
South Korea’s Sovereign Wealth Fund Turns to Biotech as Strategic Frontier for National Capital
In a move that signals the next evolution of sovereign capital, South Korea’s sovereign wealth fund is stepping deeper into the life sciences sector, underscoring how governments are increasingly deploying capital not just for returns, but for strategic positioning in critical industries. Korea Investment Corporation (KIC), the country’s $200+ billion














